ENVERIC BIOSCIENCES, INC. Interest Expense on Debt
ENVERIC BIOSCIENCES, INC. (ENVB) reported Interest Expense on Debt of $445.25 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2021-04-01
- ENVERIC BIOSCIENCES, INC. interest expense, debt for fiscal 2020 was $445.25K, a 444.16% increase from fiscal 2019.
- ENVERIC BIOSCIENCES, INC. interest expense, debt for fiscal 2019 was $81.82K.
| Period end | Interest Expense, Debt 12 month |
|---|---|
| 2020-12-31 | $445.25K 10-K · filed 2021-04-01 |
| 2019-12-31 | $81.82K 10-K · filed 2021-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |